Article
The Kir2.1E299V mutation increases atrial fibrillation vulnerability while protecting the ventricles against arrhythmias in a mouse model of short QT syndrome type 3.
Cardiovascular research - 30 Apr 2024
Moreno-Manuel Ana I, Macías Álvaro, Cruz Francisco M, Gutiérrez Lilian K, Martínez Fernando, González-Guerra Andrés, Martínez Carrascoso Isabel, Bermúdez-Jimenez Francisco José, Sánchez-Pérez Patricia, Vera-Pedrosa María Linarejos, Ruiz-Robles Juan Manuel, Bernal Juan A, Jalife José
Abstract excerpt
AIMS: Short QT syndrome type 3 (SQTS3) is a rare arrhythmogenic disease caused by gain-of-function mutations in KCNJ2, the gene coding the inward rectifier potassium channel Kir2.1. We used a multidisciplinary approach and investigated arrhythmogenic mechanisms in an in-vivo model of de-novo mutation Kir2.1E299V identified in a patient presenting an extremely abbreviated QT interval and paroxysmal atrial...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
